pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

14,968 catalysts · 3,603 8k filing · 2,670 grant · 2,420 approval · 1,702 device 510k · 1,263 device recall · 1,164 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 30 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2025-09-30×clear all
type
  • 8k filing3,603
  • grant2,670
  • approval2,420
  • device 510k1,702
  • device recall1,263
  • device pma1,164
device adverse event
1,000
  • earnings585
  • recall481
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Sep 29, 2025

    50
    ›Sep 30, 2025approval333d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

    Sponsor: AMNEAL. Form: TABLET. Route: ORAL

    full page →DOXYCYCLINE HYCLATE →fda approvals ↗
    ›Sep 30, 2025approval333d agoTRAMADOL HYDROCHLORIDE — FDA approvaltramadol hydrochloride ER

    Sponsor: MYLAN. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →tramadol hydrochloride ER →fda approvals ↗
    ›Sep 30, 2025approval333d agoMIFEPREX (MIFEPRISTONE) — FDA approvalCORCEPT THERAPEUTICS INC

    Sponsor: DANCO LABS LLC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Sep 30, 2025approval333d agoQULIPTA (ATOGEPANT) — FDA approvalatogepant

    Sponsor: ABBVIE. Form: TABLET. Route: ORAL

    full page →atogepant →fda approvals ↗
    ›Sep 30, 2025approval333d agoMIFEPRISTONE — FDA approvalMIFEPRISTONE

    Sponsor: GENBIOPRO. Form: TABLET. Route: ORAL

    full page →MIFEPRISTONE →fda approvals ↗
    ›Sep 30, 2025approval333d agoOLANZAPINE — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

    full page →fda approvals ↗
    ›Sep 30, 2025approval333d agoLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalMacleods Pharmaceuticals Ltd

    Sponsor: IPCA LABS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Sep 30, 2025approval333d agoIRBESARTAN — FDA approvalIRBESARTAN

    Sponsor: HETERO LABS LTD V. Form: TABLET. Route: ORAL

    full page →IRBESARTAN →fda approvals ↗
    ›Sep 30, 2025approval333d agoVORICONAZOLE — FDA approvalGreenstone LLC

    Sponsor: NOVEL LABS INC. Form: FOR SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Sep 30, 2025approval333d agoOLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Sep 30, 2025approval333d agoTEGRETOL-XR (CARBAMAZEPINE) — FDA approvalcarbamazepine ER

    Sponsor: NOVARTIS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →carbamazepine ER →fda approvals ↗
    ›Sep 30, 2025approval333d agoFENOFIBRIC ACID (CHOLINE FENOFIBRATE) — FDA approvalcholine fenofibrate

    Sponsor: ACTAVIS ELIZABETH. Form: CAPSULE, DELAYED RELEASE. Route: ORAL

    full page →choline fenofibrate →fda approvals ↗
    ›Sep 30, 2025approval333d agoPREGABALIN — FDA approvalPREGABALIN

    Sponsor: STRIDES PHARMA. Form: CAPSULE. Route: ORAL

    full page →PREGABALIN →fda approvals ↗
    ›Sep 30, 2025approval333d agoTEGRETOL (CARBAMAZEPINE) — FDA approvalcarbamazepine ER

    Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

    full page →carbamazepine ER →fda approvals ↗
    ›Sep 30, 2025approval333d agoRHAPSIDO (REMIBRUTINIB) — FDA approvalremibrutinib

    Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

    full page →remibrutinib →fda approvals ↗
    ›Sep 30, 2025approval333d agoMIFEPRISTONE — FDA approvalMIFEPRISTONE

    Sponsor: EVITA SOLUTIONS. Form: TABLET. Route: ORAL

    full page →MIFEPRISTONE →fda approvals ↗
    ›Sep 30, 2025approval333d agoTIZANIDINE HYDROCHLORIDE — FDA approvalRiconpharma LLC

    Sponsor: ALKEM LABS LTD. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Sep 30, 2025approval333d agoVORICONAZOLE — FDA approvalVORICONAZOLE

    Sponsor: MEITHEAL. Form: POWDER. Route: INTRAVENOUS

    full page →VORICONAZOLE →fda approvals ↗
    ›Sep 30, 2025approval333d agoCIPROFLOXACIN HYDROCHLORIDE — FDA approvalCIPROFLOXACIN HYDROCHLORIDE

    Sponsor: CHARTWELL. Form: TABLET. Route: ORAL

    full page →CIPROFLOXACIN HYDROCHLORIDE →fda approvals ↗
    ›Sep 30, 2025approval333d agoCIPROFLOXACIN HYDROCHLORIDE — FDA approvalCIPROFLOXACIN HYDROCHLORIDE

    Sponsor: CHARTWELL. Form: TABLET. Route: ORAL

    full page →CIPROFLOXACIN HYDROCHLORIDE →fda approvals ↗
    ›Sep 30, 2025approval333d agoCIPROFLOXACIN HYDROCHLORIDE — FDA approvalCIPROFLOXACIN HYDROCHLORIDE

    Sponsor: CHARTWELL. Form: TABLET. Route: ORAL

    full page →CIPROFLOXACIN HYDROCHLORIDE →fda approvals ↗
    ›Sep 30, 2025approval333d agoCIPROFLOXACIN HYDROCHLORIDE — FDA approvalCIPROFLOXACIN HYDROCHLORIDE

    Sponsor: CHARTWELL. Form: TABLET. Route: ORAL

    full page →CIPROFLOXACIN HYDROCHLORIDE →fda approvals ↗
    ›Sep 30, 2025approval333d agoCIPROFLOXACIN HYDROCHLORIDE — FDA approvalCIPROFLOXACIN HYDROCHLORIDE

    Sponsor: CHARTWELL. Form: TABLET. Route: ORAL

    full page →CIPROFLOXACIN HYDROCHLORIDE →fda approvals ↗
    ›Sep 30, 2025approval333d agoCIPROFLOXACIN HYDROCHLORIDE — FDA approvalCIPROFLOXACIN HYDROCHLORIDE

    Sponsor: CHARTWELL. Form: TABLET. Route: ORAL

    full page →CIPROFLOXACIN HYDROCHLORIDE →fda approvals ↗
    ›Sep 30, 2025approval333d agoCIPROFLOXACIN HYDROCHLORIDE — FDA approvalCIPROFLOXACIN HYDROCHLORIDE

    Sponsor: CHARTWELL. Form: TABLET. Route: ORAL

    full page →CIPROFLOXACIN HYDROCHLORIDE →fda approvals ↗
    ›Sep 30, 2025approval333d agoCIPROFLOXACIN HYDROCHLORIDE — FDA approvalCIPROFLOXACIN HYDROCHLORIDE

    Sponsor: CHARTWELL. Form: TABLET. Route: ORAL

    full page →CIPROFLOXACIN HYDROCHLORIDE →fda approvals ↗
    ›Sep 30, 2025approval333d agoLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Sep 30, 2025approval333d agoPEPCID COMPLETE (CALCIUM CARBONATE) — FDA approvalKenvue Inc.

    Sponsor: KENVUE BRANDS. Form: TABLET, CHEWABLE. Route: ORAL

    full page →fda approvals ↗
    ›Sep 30, 2025approval333d agoDASATINIB — FDA approvalXspray Pharma AB

    Sponsor: DR REDDYS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Sep 30, 2025approval333d agoLEVONORGESTREL — FDA approvalPostinor

    Sponsor: ANNORA PHARMA. Form: TABLET. Route: ORAL

    full page →Postinor →fda approvals ↗
    ›Sep 30, 2025approval333d agoMONTELUKAST SODIUM — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Sep 30, 2025approval333d agoMONTELUKAST SODIUM — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Sep 30, 2025approval333d agoMONTELUKAST SODIUM — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Sep 30, 2025approval333d agoOLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Sep 30, 2025approval333d agoZIPRASIDONE HYDROCHLORIDE — FDA approvalLupin Ltd

    Sponsor: LUPIN PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Sep 30, 2025approval333d agoLUPRON (LEUPROLIDE ACETATE) — FDA approvalInvaGen Pharmaceuticals Inc

    Sponsor: ABBVIE ENDOCRINE INC. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Sep 30, 2025approval333d agoTAMSULOSIN HYDROCHLORIDE — FDA approvalSynthon Pharmaceuticals Inc (Inactive)

    Sponsor: PHARMOBEDIENT. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Sep 30, 2025approval333d agoROPINIROLE HYDROCHLORIDE — FDA approvalropinirole hydrochloride ER

    Sponsor: ZYDUS LIFESCIENCES. Form: TABLET. Route: ORAL

    full page →ropinirole hydrochloride ER →fda approvals ↗
    ›Sep 30, 2025approval333d agoTEGRETOL (CARBAMAZEPINE) — FDA approvalcarbamazepine ER

    Sponsor: NOVARTIS. Form: SUSPENSION. Route: ORAL

    full page →carbamazepine ER →fda approvals ↗
    ›Sep 30, 2025approval333d agoNEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE (HYDROCORTISONE) — FDA approvalET-800

    Sponsor: AMNEAL. Form: SUSPENSION/DROPS. Route: OTIC

    full page →ET-800 →fda approvals ↗
    ›Sep 30, 2025approval333d agoTOFACITINIB CITRATE — FDA approvaltofacitinib citrate ER

    Sponsor: SINOTHERAPEUTICS INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →tofacitinib citrate ER →fda approvals ↗
    ›Sep 30, 2025device 510k333d agoJiangsu Bangbang Intelligent Technology Co., Ltd. — Mobility Scooter (BBR-Q40-01); Mobility Scooter (BBR-Q40-02); Mobility Scooter (BBR-Q40-03); Mobility Scooter (BBR-Q40-04); Mobility Scooter (BBR-Q40-05); Mobility Scooter (BBR-Q40-06) (510k cleared)

    Product code: INI. Advisory committee: Physical Medicine. Type: Traditional

    full page →fda device 510k ↗
    ›Sep 30, 2025device 510k333d agoMidiagnostics NV — miDiagnostics HSV-1&2 CSF Test (510k cleared)

    Product code: PGH. Advisory committee: Microbiology. Type: Traditional

    full page →fda device 510k ↗
    ›Sep 30, 2025device 510k333d agoAstrasono Technology Co., Ltd. — Astrasono A3Pro Bladder Scanner (A3Pro) (510k cleared)

    Product code: IYO. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Sep 30, 2025device 510k333d agoWright Medical Technology, Inc. (Stryker Corporation) — Allomatrix (Allomatrix Injectable Putty; Allomatrix C; Allomatrix DR; Allomatrix Custom) (510k cleared)

    Product code: MQV. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Sep 30, 2025device 510k333d agoFehling Instruments GmbH — Biopsy Forceps (510k cleared)

    Product code: DWZ. Advisory committee: Cardiovascular. Type: Special

    full page →fda device 510k ↗
    ›Sep 30, 2025device 510k333d agoParagon 28, Inc. — External Fixation Mini Rail System (510k cleared)

    Product code: KTT. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Sep 30, 2025device 510k333d agoCenters for Disease Control and Prevention — Francisella tularensis Real-time PCR assay (510k cleared)Hubei Provincial Center for Disease Control and Prevention

    Product code: SGA. Advisory committee: Immunology. Type: Traditional

    full page →fda device 510k ↗
    ›Sep 30, 2025device 510k333d agoDistalmotion SA — Dexter L6 System (510k cleared)

    Product code: SDD. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Sep 30, 2025device 510k333d agoArthrex, Inc. — Arthrex SpeedFLEX™ Implant (510k cleared)

    Product code: OWY. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ← prev
    page 1 of 300
    next →
    $AMRX17.54-2.61%
    $NVS153.81-0.54%
    $AMRX17.54-2.61%
    $ABBV259.04-1.47%
    $CORT113.88-2.61%
    $KVUE19.20-0.10%
    $NVS153.81-0.54%
    $NVS153.81-0.54%
    $AMRX17.54-2.61%
    $AMRX17.54-2.61%
    $AMRX17.54-2.61%
    $SIGY0.04000.00%
    $NVS153.81-0.54%